Zhang F, Liu H, Li J, et al. Outcomes of amyloidosis patients in the intensive care unit: A systematic review and meta-analysis. J Crit Care. 2024;79:154317
Kumar S, Sidana S, Dispenzieri A, et al. Contemporary outcomes of patients with light chain amyloidosis in the intensive care setting: a multi-center cohort study. Leukemia. 2024;38(1):176-185.
Donnelly JP, Hanna M. Cardiac amyloidosis: An update on diagnosis and treatment. Cleve Clin J Med. 2023;90(1):37-50.
Palladini G, Milani P, Merlini G. Management of AL amyloidosis in 2023. Blood. 2023;141(8):841-857.
Garcia-Pavia P, Rapezzi C, Adler Y, et al. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on myocardial and pericardial diseases. Eur Heart J. 2021;42(16):1554-1568.
Law S, Petrie A, Chacko L, et al. AL amyloidosis in the ICU: outcomes and prognostic factors. Eur J Heart Fail. 2022;24(6):1071-1080.
Chen Z, Wang Y, Miao W, et al. Diagnostic delay in cardiac amyloidosis: A systematic review and meta-analysis. ESC Heart Fail. 2023;10(5):3879-3889.
Mahmood S, Venner CP, Sachchithanantham S, et al. Outcomes and prognostic factors of patients with immunoglobulin light chain amyloidosis admitted to the intensive care unit. Br J Haematol. 2022;196(5):1142-1152.
